Global Assets Advisory LLC Acquires 2,126 Shares of UnitedHealth Group Incorporated $UNH

Global Assets Advisory LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 66.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,325 shares of the healthcare conglomerate’s stock after acquiring an additional 2,126 shares during the quarter. Global Assets Advisory LLC’s holdings in UnitedHealth Group were worth $1,737,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock valued at $4,257,131,000 after buying an additional 196,696 shares during the last quarter. Nuveen LLC acquired a new position in UnitedHealth Group in the 1st quarter valued at approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have commented on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. KeyCorp reduced their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Finally, Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Price Performance

UNH stock opened at $360.17 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market capitalization of $326.20 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The company’s 50-day moving average is $307.84 and its 200-day moving average is $353.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the company posted $6.80 EPS. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.